TIFFANY KESSLER: Open Payments
NPI 1194197947 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,590 in 17 payments from 6 companies in 2025. Trend: 2023 $29,436 · 2024 $18,072 · 2025 $4,590
Speaker / faculty: $3,014Travel & lodging: $715Consulting: $580Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $4,433 |
| ABBVIE INC. | 3 | $53 |
| Stemline Therapeutics Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Tempus AI, Inc | 1 | $15 |
Products named: Trodelvy, EPKINLY, Orserdu, Xofigo, ENHERTU, XT CDX.
Industry payments across TX — which companies pay providers there.
